Wearable Monitoring Device in Daily Lives of Community-dwelling Older Adults

September 20, 2023 updated by: Arkers, Wong, The Hong Kong Polytechnic University

Optimizing the Health-related Functions of a Wearable Monitoring Device in the Daily Life of Community-dwelling Older Adults: A Randomized Pilot Study

The aim is to implement an intervention program to promote the continued use of Wearable Monitoring Devices among older adults through a peer support approach facilitating the incorporation of Wearable Monitoring Devices in daily life.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

72

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • aged 60 or above
  • own a smartphone
  • able to communicate in Cantonese or Mandarin
  • able to access the Internet at home or elsewhere

Exclusion Criteria:

  • have a confirmed diagnosis of cognitive impairment
  • bed-bound
  • currently own a wearable monitoring device
  • have already engaged in other wearable device studies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
Participants will receive a 3-month Live With Wearable Monitoring Device program.
The participants in the intervention group will receive a home visit by a Community Healthcare Worker in the first month, and biweekly motivational messages via Whats App in the second and third months.
No Intervention: Control group
Usual care. As with the participants in the intervention group, those in the control group can utilize the features in the Wearable Monitoring Device.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The change of use intention of wearable monitoring device
Time Frame: Data collection will be conducted at the 1-month (T1), 3-month (T2), and 6-month (T3) time points
It will be measured using a 4-item, 5-point Likert scale adopted from Bhattacherjee (2001) and Windasari et al. (2021). The five-point scale ranges from 1 = not at all satisfied to 5 = very certain, with higher scores representing a higher chance of continuing to use the WMD.
Data collection will be conducted at the 1-month (T1), 3-month (T2), and 6-month (T3) time points

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The change of adherence rate of wearing wearable monitoring device
Time Frame: Data collection will be conducted at the 1-month (T1), 3-month (T2), and 6-month (T3) time points
It will be measured by checking in our database the number of days that participants wore their device, and the average amount of time worn per day. Longer time worn represents better adherence rate
Data collection will be conducted at the 1-month (T1), 3-month (T2), and 6-month (T3) time points
The change in quality of life among baseline (T0) and at the 1-month (T1), 3-month (T2), and 6-month (T3) time points
Time Frame: baseline (T0) and at the 1-month (T1), 3-month (T2), and 6-month (T3) time points
Quality of life will be measured using the Hong Kong version of the EuroQol 5-dimension scale. The EQ-5D-5L is comprised of five dimensions, namely, mobility, self-care, usual activities, pain or discomfort, and anxiety or depression. The utility score ranges from 0 to 1, with higher means better quality of life
baseline (T0) and at the 1-month (T1), 3-month (T2), and 6-month (T3) time points
The change of health service utilization among baseline (T0) and at the 1-month (T1), 3-month (T2), and 6-month (T3) time points
Time Frame: baseline (T0) and at the 1-month (T1), 3-month (T2), and 6-month (T3) time points
ealth service utilization includes the number of attendances at a general practitioner's office, emergency department, hospital, and general out-patient clinic. The data will be reported by the participants and confirmed with medical and attendance certificates
baseline (T0) and at the 1-month (T1), 3-month (T2), and 6-month (T3) time points
Recruitment rate
Time Frame: baseline pre-intervention
The recruitment rate will be calculated by dividing the number of participants who are recruited and randomized, by the number of eligible participants.
baseline pre-intervention
Attrition rate
Time Frame: 6-month (T3) time points
The attrition rate refers to the number of participants who withdraw from the study or who are lost to follow up.
6-month (T3) time points
Incidence of reports of adverse events
Time Frame: 6-month (T3) time points
the incidence of reports of adverse events will be recorded by a staff member assigned to each of the community centres and a nurse
6-month (T3) time points
Incidence of reports of technical difficulties
Time Frame: 6-month (T3) time points
Incidence of reports of technical difficulties will be recorded by a staff member assigned to each of the community centres and a nurse
6-month (T3) time points
The change of perceived usability of the wearable monitoring device before and after the program
Time Frame: baseline pre-intervention, 6-month (T3) time points
The participants will be required to complete a questionnaire that measures their attitude towards using the WMD; the perceived usefulness, perceived ease of use, and self-efficacy of using the device; and their level of anxiety about using the device. The questionnaire was drawn up by Chen and Chan (2014). This 10-point Likert scale ranges from 1 (strongly disagree) to 10 (strongly agree), with higher marks indicating a better outcome, with the exception of the item on anxiety levels, where higher marks represent a higher level of anxiety in using the WMD.
baseline pre-intervention, 6-month (T3) time points

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Arkers Wong, Ph.D., The Hong Kong Polytechnic University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 10, 2022

Primary Completion (Actual)

July 9, 2023

Study Completion (Actual)

July 9, 2023

Study Registration Dates

First Submitted

February 24, 2022

First Submitted That Met QC Criteria

March 3, 2022

First Posted (Actual)

March 7, 2022

Study Record Updates

Last Update Posted (Actual)

September 22, 2023

Last Update Submitted That Met QC Criteria

September 20, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • A001523

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Device Ineffective

Clinical Trials on Live With Wearable Monitoring Device program

Subscribe